In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei.
作者信息
Ashdown L R
机构信息
Pathology Laboratory, Commonwealth Department of Community Services and Health, Townsville, Queensland, Australia.
出版信息
Antimicrob Agents Chemother. 1988 Sep;32(9):1435-6. doi: 10.1128/AAC.32.9.1435.
Abstract
Imipenem was highly active and bactericidal against all 100 strains of Pseudomonas pseudomallei tested, followed in activity by piperacillin, carumonam, ceftazidime, cefotaxime, and ceftriaxone. The addition of clavulanic acid significantly increased the activities of both amoxicillin and ticarcillin. Ciprofloxacin and norfloxacin showed poor activity against test strains.
摘要
相似文献
1
In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomallei.
Antimicrob Agents Chemother. 1988 Sep;32(9):1435-6. doi: 10.1128/AAC.32.9.1435.
2
In vitro activities of 36 antimicrobial agents against clinically isolated Bacteroides fragilis.
J Formos Med Assoc. 1991 Aug;90(8):796-9.
3
Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.
Antimicrob Agents Chemother. 1991 Mar;35(3):484-9. doi: 10.1128/AAC.35.3.484.
4
In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents.
Antimicrob Agents Chemother. 1990 Oct;34(10):2027-9. doi: 10.1128/AAC.34.10.2027.
5
[Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
Pathol Biol (Paris). 1997 May;45(5):433-7.
6
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Diagn Microbiol Infect Dis. 1998 Mar;30(3):215-28. doi: 10.1016/s0732-8893(97)00234-4.
7
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.
Diagn Microbiol Infect Dis. 1995 Jul;22(3):285-91. doi: 10.1016/0732-8893(95)00096-s.
8
Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins & newer cephalosporins against Pseudomonas species.
Indian J Med Res. 1992 May;95:136-8.
9
Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates.
Antimicrob Agents Chemother. 2002 Jan;46(1):234-8. doi: 10.1128/AAC.46.1.234-238.2002.
10
The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.
J Antimicrob Chemother. 1989 Sep;24(3):295-309. doi: 10.1093/jac/24.3.295.
引用本文的文献
1
Glanders ( infection) in an Iranian man: A case report.
IDCases. 2023 Apr 29;32:e01779. doi: 10.1016/j.idcr.2023.e01779. eCollection 2023.
2
Melioidosis Pneumonia in Saudi Arabia: A Rare Case Report and Review of the Literature.
Cureus. 2022 Feb 3;14(2):e21871. doi: 10.7759/cureus.21871. eCollection 2022 Feb.
3
Human Melioidosis.
Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00006-19. Print 2020 Mar 18.
4
Imported Case of Melioidosis in Oman: Case Report.
Oman Med J. 2017 Jan;32(1):62-65. doi: 10.5001/omj.2017.11.
5
Emergence of pediatric melioidosis in Siem Reap, Cambodia.
Am J Trop Med Hyg. 2010 Jun;82(6):1106-12. doi: 10.4269/ajtmh.2010.10-0030.
6
Present and future therapeutic strategies for melioidosis and glanders.
Expert Rev Anti Infect Ther. 2010 Mar;8(3):325-38. doi: 10.1586/eri.10.4.
7
Melioidosis: epidemiology, pathophysiology, and management.
Clin Microbiol Rev. 2005 Apr;18(2):383-416. doi: 10.1128/CMR.18.2.383-416.2005.
8
Fluoroquinolone antimicrobial agents.
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
9
Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.
Antimicrob Agents Chemother. 1991 Mar;35(3):484-9. doi: 10.1128/AAC.35.3.484.
10
Melioidosis: the tip of the iceberg?
Clin Microbiol Rev. 1991 Jan;4(1):52-60. doi: 10.1128/CMR.4.1.52.
本文引用的文献
1
Meliodosis.
Med J Aust. 1980 Apr 5;1(7):314-6.
2
Melioidosis in the Northern Territory of Australia.
Med J Aust. 1981 Feb 21;1(4):181-4. doi: 10.5694/j.1326-5377.1981.tb135443.x.
3
Melioidosis in Far North Queensland. A clinical and epidemiological review of twenty cases.
Am J Trop Med Hyg. 1984 May;33(3):467-73. doi: 10.4269/ajtmh.1984.33.467.
4
In vitro activity of various cephalosporins against Pseudomonas pseudomallei.
J Infect Dis. 1984 Nov;150(5):779-80. doi: 10.1093/infdis/150.5.779.
5
Successful treatment of melioidosis caused by a multiresistant strain in an immunocompromised host with third generation cephalosporins.
Am Rev Respir Dis. 1983 May;127(5):650-4. doi: 10.1164/arrd.1983.127.5.650.
6
The pseudomallei group: a review.
J Infect Dis. 1971 Dec;124(6):598-606. doi: 10.1093/infdis/124.6.598.
7
Subacute pulmonary melioidosis in a temperate climate.
Med J Aust. 1987 Jul 20;147(2):95-6. doi: 10.5694/j.1326-5377.1987.tb133271.x.
8
In-vitro susceptibility of Pseudomonas pseudomallei isolated in Malaysia to some new cephalosporins and a quinolone.
Southeast Asian J Trop Med Public Health. 1987 Mar;18(1):94-6.
9
In vitro susceptibility of strains of Pseudomonas pseudomallei isolated in Thailand and Hong Kong to some newer beta-lactam antibiotics and quinolone derivatives.
J Infect Dis. 1986 Jan;153(1):167-70. doi: 10.1093/infdis/153.1.167.
10
Identification of Pseudomonas pseudomallei in the clinical laboratory.
J Clin Pathol. 1979 May;32(5):500-4. doi: 10.1136/jcp.32.5.500.
Zotero 插件